Results 111 to 120 of about 16,360 (195)

Costimulation Blockade Increases Risk of Ventricular Rupture in a Preclinical Model of Transmural Myocardial Injury. [PDF]

open access: yesJACC Basic Transl Sci
Sicklinger F   +6 more
europepmc   +1 more source

Pioderma gangrenoso paradosso da Abatacept.

open access: yes, 2017
Il pioderma gangrenoso è una rara dermatosi neutrofilica non infettiva che colpisce solitamente gli arti inferiori. Si presenta più comunemente con pustole sterili che evolvono in ulcerazioni dolorose con bordi sottominati eritemato-violacei.
Mantovani L   +4 more
core  

Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis

open access: yes, 2006
Objective. Abatacept, a soluble selective costimulation modulator, selectively modulates T cell activation via the CD80/CD86:CD28 costimulation pathway.
Weisman, Michael H.   +8 more
core  

Persistence Among Biologic/JAKi-Naive Medicare Beneficiaries with RA Initiating Synthetic DMARDs. [PDF]

open access: yesRheumatol Ther
Schwartz TT   +10 more
europepmc   +1 more source

Pregnancy and infant outcomes following abatacept exposure during pregnancy. [PDF]

open access: yesRheumatol Adv Pract
Chambers CD   +10 more
europepmc   +1 more source

PO:06:084 | Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study

open access: yesReumatismo
Background. Abatacept has been suggested to be a safe and effective drug for the treatment of rheumatoid arthritis (RA) complicated by interstitial lung disease (ILD), one of the most severe extra-articular manifestations of RA. Objectives.
Società Italiana di Reumatologia
doaj  

Abatacept in the treatment of active rheumatoid arthritis

open access: yes, 2009
Abatacept (CTLA4Ig) is a human fusion protein which consists of a cytotoxic lymphocytic-associated type 4 antigen which is bound to the Fc part of the IgG1.
Hansen, Annette, Nielsen, Henrik
core  

Home - About - Disclaimer - Privacy